Fig. 2From: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinomaThe prediction accuracy of the efficacy prediction model for NPC patients treated with PD-1 inhibitors. A Receiver operating characteristic (ROC) curves of a prediction model in the training cohort; B Calibration curve of a prediction model in the training cohort; C Clinical impact curve of a prediction model in the training cohort; D Receiver operating characteristic (ROC) curves of a prediction model in the validation cohort; E Calibration curve of a prediction model in the validation cohort; F Clinical impact curve of a prediction model in the validation cohortBack to article page